ChiroACCESS Clinical Review



Fibromyalgia: Prevention

This information is provided to you for use in conjunction with your clinical judgment and the specific needs of the patient.

Lead Author(s): 

Dwain M. Daniel, D.C.

  

How this evidence was rated:

Strength of Recommendation Taxonomy (SORT)



Published on

October 1, 2006

Text Size:     
Fibromyalgia is a condition of unknown etiology. Several theories as to etiology of FM have been proposed but none have been validated. Two of the more accepted theories are sensitization of the central nervous system (1;2) and dysfunction of the hypothalamic-pituitary-adrenal axis (1;3). Consequently, rather than providing prevention strategies based on etiology, one must look at demographics to identify factors that co-exist or pre-existed and may contribute to the condition in individuals with diagnosed fibromyalgia. Using this information may aid the physician in developing strategies for reducing occurrence of fibromyalgia or at least reducing symptomology in the fibromyalgia patient.

AttentionIn order to view the full content of this review, which includes information broken down by topic, you must be a registered user of ChiroACCESS. The primary mission of ChiroACCESS is to disseminate accurate user-friendly information to practicing chiropractors, faculty and students of chiropractic in order to ensure the best possible patient care.

Please click on the following link in order to register at ChiroACCESS and view the full detail of this clinical review.

If you already have an account, you may log in at this time.



References

1. 

Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005; 75:6-21.



2. 

Staud R. Fibromyalgia pain: do we know the source? Curr Opin Rheumatol 2004; 16(2):157-163.



3. 

Neeck G, Crofford LJ. Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 2000; 26(4):989-1002.



4. 

Forseth KO, Husby G, Gran JT, Forre O. Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study. J Rheumatol 1999; 26(11):2458-2467.



5. 

Marinus J, Van Hilten JJ. Clinical expression profiles of complex regional pain syndrome, fibromyalgia and a-specific repetitive strain injury: more common denominators than pain? Disabil Rehabil 2006; 28(6):351-362.



6. 

Raphael KG, Janal MN, Nayak S. Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women. Pain Med 2004; 5(1):33-41.



7. 

Walker EA, Keegan D, Gardner G, Sullivan M, Bernstein D, Katon WJ. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosom Med 1997; 59(6):572-577.



8. 

Ciccone DS, Elliott DK, Chandler HK, Nayak S, Raphael KG. Sexual and physical abuse in women with fibromyalgia syndrome: a test of the trauma hypothesis. Clin J Pain 2005; 21(5):378-386.



9. 

Kivimaki M, Leino-Arjas P, Virtanen M, Elovainio M, Keltikangas-Jarvinen L, Puttonen S et al. Work stress and incidence of newly diagnosed fibromyalgia: prospective cohort study. J Psychosom Res 2004; 57(5):417-422.



10. 

Forseth KO, Forre O, Gran JT. A 5.5 year prospective study of self-reported musculoskeletal pain and of fibromyalgia in a female population: significance and natural history. Clin Rheumatol 1999; 18(2):114-121.



11. 

Eriksen W. Linking work factors to neck myalgia: the nitric oxide/oxygen ratio hypothesis. Med Hypotheses 2004; 62(5):721-726.



12. 

Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K et al. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res 2004; 57(4):391-398.



13. 

Regland B, Andersson M, Abrahamsson L, Bagby J, Dyrehag LE, Gottfries CG. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol 1997; 26(4):301-307.



14. 

Nakamura T, Saionji K, Hiejima Y, Hirayama H, Tago K, Takano H et al. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients. Am J Kidney Dis 2002; 39(5):1032-1039.



15. 

Lipworth L, Tarone RE, McLaughlin JK. Breast implants and fibromyalgia: a review of the epidemiologic evidence. Ann Plast Surg 2004; 52(3):284-287.